SCOLR Pharma, Inc. to Present at Taglich Brothers 7th Annual Small Cap Equity Conference

NEW YORK, NY--(Marketwire - April 16, 2010) -  Taglich Brothers, Inc. is pleased to announce that Stephen Turner, President & CEO, and Richard Levy, CFO, of SCOLR Pharma, Inc. (NYSE Amex: DDD) will be presenting at our 7^th Annual Small Cap Equity Conference May 4^th, 2010. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit www.taglich.com.

About Taglich Brothers

Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.

About SCOLR Pharma

Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

Contact Information:

Contact:
Taglich Brothers
Karen Payne
212-779-2971